Top compounds associated with response to LGALS1


Feature Type Standardized
Nominal ANOVA
mRNA NSC-207895 GDSC1000 pan-cancer AAC -0.11 0.002
mRNA LAQ824 GDSC1000 pan-cancer AAC -0.11 0.002
mRNA SB-525334 CTRPv2 pan-cancer AAC -0.13 0.002
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA MI-2 CTRPv2 pan-cancer AAC -0.18 0.002
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC 0.11 0.002
mRNA 17-AAG CCLE pan-cancer AAC 0.15 0.002
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.1 0.002
mRNA CCT007093 GDSC1000 pan-cancer AAC 0.11 0.002
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
Download CSV